CompletedPhase 4NCT01367743
Study Comparing the Efficacy and Tolerability of Epinephrine and Norepinephrine in Cardiogenic Shock
Studying Cardiogenic shock
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Central Hospital, Nancy, France
- Principal Investigator
- Philippe VIGNON, DrCHU Limoges
- Intervention
- epinephrine perfusion(drug)
- Enrollment
- 58 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2011 – 2016
Study locations (11)
- Nancy Brabois university hospital, Vandœuvre-lès-Nancy, Meurthe Et Moselle, France
- CHU de BESANCON / Hôpital Jean Minjoz, Besançon, France
- CHU de DIJON, Dijon, France
- CHU de LIMOGES Hôpital Dupuytren, Limoges, France
- APHM Hôpital NORD, Marseille, France
- Chr Metz Thionville, Metz, France
- CH de MULHOUSE, Mulhouse, France
- AP-HP-Hôpital Cochin, Paris, France
- CHU de STRASBOURG / NHC, Strasbourg, France
- CHU Toulouse, Toulouse, France
- Chru Tours, Tours, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01367743 on ClinicalTrials.govOther trials for Cardiogenic shock
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT07527156Prolonged Nasogastric Administration of Ketones in Decompensated Heart FailureInstitute for Clinical and Experimental Medicine
- RECRUITINGNANCT07345559Personalisation of Mean Arterial Pressure in Adult Patients With Cardiogenic ShockCMC Ambroise Paré
- RECRUITINGNANCT07374289On Scene ECPR in OstravaUniversity Hospital Ostrava
- RECRUITINGNCT07402018Intra-aortic Balloon Counterpulsation (IABC) ComplianceThomas Jefferson University
- RECRUITINGNCT07309029Pre-Emptive LAVA-ECMO for Complex High-Risk TAVRAtlantic Health System
- RECRUITINGNANCT07293923Magenta Elevate™ Clinical Feasibility Study in Cardiogenic ShockMagenta Medical Ltd.
- RECRUITINGNCT07354568Prognosis of Patients With Mixed Cardiogenic-Vasoplegic ShockCentre Hospitalier Universitaire, Amiens
- RECRUITINGNCT06964685Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic ShockAbiomed Inc.